
Widely Used Thyroid Drug May Accelerate Bone Loss in Older Adults
A study presented at the Radiological Society of North America suggests that levothyroxine, a common thyroid medication, may lead to reduced bone mass and density in older adults with normal thyroid levels. Conducted by Johns Hopkins University researchers, the study involved 81 participants over 65 and found bone loss over a 6-year period. This raises concerns about the potential overprescription of levothyroxine and its side effects, including increased osteoporosis risk, in older adults.




